Australian Specialist Develops New Tools for the Fight Against Hepatitis B
- Details
- Category: 2012
- Last Updated on Friday, 03 August 2012 01:57
Liverpool Hospital, Sydney NSW, at the launch of a set of innovative educational resources designed to improve the treatment rates of Australia’s approximately 170,000 hepatitis B sufferers and reduce the incidence of hepatitis B-related liver cancer and liver failure:
L to R:
Professor Stephen Locarnini, Director, World Health Organisation (WHO) Regional Reference Laboratory for Hepatitis B at the Victorian Infectious Diseases Reference Laboratory; Dr Kerry Chant, Chief Health Officer, NSW; Dr Miriam Levy, Head of Gastroenterology and Hepatology at Liverpool Hospital in Sydney
For more details:
CEVHAP - NSW Health Joint Press Release, 23 July 2012
>> PRESS RELEASES
|
2017 |
| APASL 2017 | |
 |
English |
|
2016 |
|
|
CEVHAP Asia Pacific Hepatitis Policy 2016 Survey finds Asia Pacific on path to eliminating viral hepatitis |
| APASL 2016 | |
|
English |
|
2015 |
| WHD 2013 | |
|
English |
|
Chinese |
|
APASL 2013 |
|
|
|
CEVHAP welcomes the launch and dedicates their support to the Global Hepatitis Network |
|
2012 |
|
WHD 2012 |
|
|
CEVHAP WHD 2012 Press Release |
|
CEVHAP-NSW Health Joint Press Release in Australia |
| APASL 2012 | |
|
CEVHAP Symposium Announcement |
|
2011 |
|
| WHD 2011 | |
|
China (Chinese) |
|
India |
|
Indonesia (Bahasa) |
|
CEVHAP-KASL WHD Joint Press Release in Korea (Korean) |
|
Malaysia |
|
Hong Kong (English) |
|
Hong Kong (Chinese) |
Connect with us
